Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
about
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.Association between features of patient-provider discussions and routine prostate-specific antigen testingIncreasing detection of significant prostate cancer in younger men - ten year trends in prostate cancer risk profile in the Mid-West of Ireland.Emerging proteomics biomarkers and prostate cancer burden in Africa.Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate.Emerging minimally invasive procedures for focal treatment of organ-confined prostate cancer.Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.Personalized prostate cancer care: from screening to treatment.Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide.Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.Germline genetic variants in men with prostate cancer and one or more additional cancers.Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.Increasing Urologic Care Ratios: Implications of Male Patient Care in Florida.Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.What's new in screening in 2015?Early estimates of SEER cancer incidence, 2014.African-American and Caribbean-Born Men's Perceptions of Prostate Cancer Fear and Facilitators for Screening Behavior: a Pilot Study.Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.Preliminary estimates of SEER cancer incidence for 2013.Early-stage prostate cancer, PSA screening rates decline.Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.Making the grade: The newest US Preventive Services Task Force prostate cancer screening recommendation.Prostate cancer incidence as an iceberg.Changes in thyroid cancer incidence, post-2009 American Thyroid Association guidelines.Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer.Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening.Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospitalThe number of key carcinogenic events can be predicted from cancer incidencePositive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy - An analysis of outcomes from a UK tertiary referral centre.Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.
P2860
Q30239973-F1D8768F-9AE7-4DA9-8186-DB9FBA5C3C31Q30746254-E0ABA2BB-9096-4779-B64A-5B0437602BA2Q30847275-4ABB57CA-4949-4CE1-8CC3-963361338862Q33693841-3371A0E3-94E6-445E-9F1A-080FD4496800Q33904126-61A157F7-EE55-4780-B2D5-EF59D343093CQ33914221-120F9EF2-0D39-45C3-97AD-6A424B6CBFE9Q35953470-ECA8FB17-197B-4A34-8AED-747E9EE4AF3BQ36065097-320013A2-3C97-444F-B2B0-3A58884C5FC4Q37059322-C08E1CEF-B3D6-4671-A73B-34C813567AA4Q37113160-4E8480B2-005E-4557-A6EE-52BA9A4B3AD6Q37273869-EA204155-BEFF-4AA3-89F0-232CDAADD813Q37280666-293352FE-47DA-4B7F-94DE-A961B2307B94Q37622580-531BFF3E-3716-4B52-B75A-2AF52B16B3D7Q38684598-7217D09C-502D-4B00-BDE5-A37A6B044B2FQ38705089-7F09F175-4734-4665-90BA-E2DCD480D990Q38807025-6333D20A-314A-4A29-AB58-8807A61145D4Q38830764-D7E004AC-99C6-4196-A11E-DB3B81E3DA35Q38843182-2C62585B-18C8-461E-95CD-68533F5E8188Q38871819-58042808-97F1-437E-AFF6-E17687E5B8EDQ38962389-96FF7159-E81F-4C8C-BB8E-9E4CD7C2459CQ39017563-8C828C15-9267-4C7D-B750-EBAD0D094E9CQ39204570-3B58B46E-1AAA-46B7-80E4-9BBB19570040Q39362101-18A45809-C38C-4BED-A93A-DEA382CDBA41Q39554008-D22BA931-E6C3-4B99-AD7A-116AA43A24C6Q39587746-FBCE1501-4D22-4975-933E-591E0C8BBCD1Q39639104-720DCB36-FEF1-41A0-A48A-3E1CA6B17B5DQ39908476-3367263C-585B-4849-987B-80B9DFE69EF4Q39951175-1C96E5DB-4FA9-4344-93CB-AC3DE651FDDBQ39972544-653915D5-3525-4245-83C9-5327F53D5E6EQ40073917-80D6FCD5-7F0B-430C-ACEC-9193A29F3E83Q40179631-3619C0C4-493C-4A55-937D-CCF132476CE2Q40379261-1D8D67BA-ADBD-442A-A8EA-9E0A6959D58CQ40852349-82E09241-9608-4F67-932D-1F1292F49A6CQ40967992-BA9103E9-9C52-461B-8403-13C76F010D04Q41032260-FFE615D3-0835-4B34-A2BC-3714BA0CACD4Q41212675-D867AF2A-FFC3-4012-B1EB-D5E336199CE5Q41240464-8DBEF0D3-1B02-409C-AA3D-611D13374AC8Q41903144-5634833D-2610-45DB-9A1D-95BC33FA18BDQ42284813-35D21511-EBDC-45BB-A1D2-EA1D8C17BE07Q42345805-2886C4D2-ED73-496D-B081-6769C50661D0
P2860
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prostate Cancer Incidence and ...... STF Screening Recommendations.
@en
type
label
Prostate Cancer Incidence and ...... STF Screening Recommendations.
@en
prefLabel
Prostate Cancer Incidence and ...... STF Screening Recommendations.
@en
P2093
P356
P1476
Prostate Cancer Incidence and ...... STF Screening Recommendations.
@en
P2093
Ahmedin Jemal
Chun Chieh Lin
Elizabeth M Ward
Otis Brawley
Rebecca Siegel
Stacey A Fedewa
P304
P356
10.1001/JAMA.2015.14905
P407
P577
2015-11-01T00:00:00Z